Clinical Trial Update: Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL [Phase 2]

View source ↗

Summary

A completed Phase II trial evaluating a therapeutic vaccine for human papillomavirus infection in women with normal cytology or ASCUS/LSIL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HPV Therapeutic Vaccine

Snippet

Sponsor: Genticel | Conditions: Genital Infection Viral, HUMAN PAPILLOMA VIRUS | Phase 2 | Status: COMPLETED